Clincosm LogoSign in Get a demo

Network Analysis of Adult MDD and ADHD

Sponsor
Health Sciences North Research Institute (Other)
Overall Status
Unknown status
CT.gov ID
NCT04504474
Collaborator
(none)
500
Enrollment
1
Location
38.6
Anticipated Duration (Months)
13
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The study is an investigation to determine co-morbid symptoms between adult major depressive disorder (MDD) and adult attention-deficit hyperactivity disorder (ADHD) using a novel statistical technique called network analysis.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    500 participants
    Observational Model:
    Cohort
    Time Perspective:
    Other
    Official Title:
    Network Analysis of Co-morbid Symptoms of Adult Major Depressive Disorder and Attention-deficit Hyperactivity Disorder in an Outpatient Population
    Actual Study Start Date :
    Jun 21, 2018
    Anticipated Primary Completion Date :
    Aug 8, 2021
    Anticipated Study Completion Date :
    Sep 8, 2021

    Outcome Measures

    Primary Outcome Measures

    1. Co-morbidity [September 8, 2021]

      Characterize the ADHD/MDD symptom network in a psychiatric outpatient setting comprised of adults

    2. Network reliability [September 8, 2021]

      Determine the stability and reliability of this network

    3. Central symptoms [September 8, 2021]

      Determine the central symptoms that lead to co-activation of ADHD/MDD clusters

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 60 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    • participants have a diagnosis of MDD or ADHD or both

    • participants are competent to consent to the study

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Kirkwood Site - Health Sciences North Sudbury Ontario Canada P3E 1X3

    Sponsors and Collaborators

    • Health Sciences North Research Institute

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Health Sciences North Research Institute
    ClinicalTrials.gov Identifier:
    NCT04504474
    Other Study ID Numbers:
    • 18-056
    First Posted:
    Aug 7, 2020
    Last Update Posted:
    Aug 7, 2020
    Last Verified:
    Aug 1, 2020
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No

    Study Results

    No Results Posted as of Aug 7, 2020